Cardio Diagnostics Holdings Inc Warrant
CDIOW
22 hedge funds and large institutions have $6.72M invested in Cardio Diagnostics Holdings Inc Warrant in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$119K |
| 2 |
SCM
Saba Capital Management
New York
|
+$56K |
| 3 |
CCM
Context Capital Management
Lajolla,
California
|
+$29.7K |
| 4 |
ASM
ATW SPAC Management
New York
|
+$23.8K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$23.8K |
Top Sellers
CDIOW Hedge Fund Activity: Q1 2022 in Review
22 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in Cardio Diagnostics Holdings Inc Warrant (CDIOW) for Q1 2022, worth a combined $6.72M.
Buyers outnumbered sellers: 22 funds opened new CDIOW positions and 0 closed out — a net gain of 22 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Mangrove Partners, opening a new position worth an estimated $119K.
- 22 institutional investors held Cardio Diagnostics Holdings Inc Warrant (CDIOW) as of Q1 2022, up from 0 in Q4 2021.
- Funds reported $6.72M of Cardio Diagnostics Holdings Inc Warrant stock for Q1 2022.
- 22 funds opened new Cardio Diagnostics Holdings Inc Warrant positions in Q1 2022 and 0 closed out, a net change of +22 holders.
- The largest Cardio Diagnostics Holdings Inc Warrant buyer in Q1 2022 was Mangrove Partners, an estimated $119K added.
Based on aggregated 13F filings for Q1 2022.